Intelerad | AI Transformation Index
Intelerad is a high-durability, moderate-opportunity asset — the system-of-record infrastructure layer in enterprise medical imaging that AI augments rathe...

Overview
Intelerad develops and sells cloud-first enterprise medical imaging software (PACS, VNA, workflow orchestration) to healthcare providers on a subscription basis, generating ~90% recurring revenue by embedding deeply into radiology and cardiology workflows across inpatient and outpatient settings.
Executive Summary
Intelerad is a high-durability, moderate-opportunity asset — the system-of-record infrastructure layer in enterprise medical imaging that AI augments rather than replaces. Its structural position is strong: deeply embedded in health system workflows, protected by regulatory complexity and massive migration costs, and increasingly positioned as the orchestration hub through which AI diagnostic models are deployed. The AI opportunity is meaningful primarily as a platform expansion play — Intelerad can evolve from workflow infrastructure to clinical intelligence infrastructure — but because it is already a technology-native company with an advanced engineering team and active AI partnerships, the unrealized step-change is moderate rather than transformative; this is not a cognitive-labor compression story, it is a platform strategic evolution story.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
69.8
Ciridae AI Score
Durability Rationale
Intelerad occupies the system-of-record position in enterprise medical imaging — the infrastructure layer that AI models plug into rather than replace. Its structural protection is strong: healthcare regulatory complexity, petabyte-scale data migration costs, and deep EHR/RIS integration create switching barriers that even well-funded AI-native entrants cannot easily overcome. The key durability risk is platform-level commoditization if cloud hyperscalers or GE HealthCare's own roadmap (post-acquisition) absorbs the workflow layer, but the multi-year contract structure and embedded workflow customization provide meaningful time horizons before that pressure materializes.
Opportunity Rationale
The AI opportunity for Intelerad is real but fundamentally different in character from cognitive-labor businesses — it is a platform expansion story, not a workforce compression story. Intelerad's most significant opportunity is evolving from a passive imaging infrastructure provider into an active AI orchestration hub, integrating diagnostic AI models, enabling intelligent study triage, and positioning itself as the integration backbone for the AI-augmented radiology workflow. This is a meaningful but incremental step-change rather than an order-of-magnitude transformation, given that the company is already a technology-native platform with an advanced engineering team and active AI partnerships already in flight.
Key Risks
The GE HealthCare acquisition (completed post-hold period) represents the primary durability risk crystallized: as a division of a large OEM, Intelerad's platform independence and neutral vendor positioning could erode, accelerating competitor consolidation around Philips, Sectra, or new cloud-native entrants — compressing the switching cost moat if health systems seek non-GE alternatives.
The opportunity assessment could be wrong if AI diagnostic model vendors (e.g., Nuance/Microsoft, Aidoc, or a foundation model player) build their own workflow layers and bypass the PACS/VNA infrastructure entirely, making Intelerad's platform a commodity storage layer rather than an AI orchestration hub — limiting the platform expansion upside.
Company Overview
| Headquarters | Raleigh, North Carolina, United States |
| Products / Services | Medical imaging software solutions for healthcare providers, including enterprise imaging platforms designed for complex, multi-site health systems. |
| Deal Partners |
AI & Tech Initiatives
| Name | Description |
|---|---|
| Partnership with RADPAIR | Intelerad partnered with RADPAIR, a company specializing in generative and agentic AI-driven radiology solutions. This partnership integrates RADPAIR's generative and agentic AI technology with Intelerad's workflow orchestration platform, InteleOrchestrator™. The combined solution automates large portions of radiology reporting workflows, allowing radiologists to generate precise, professional reports rapidly by speaking naturally without needing structured commands or cursor controls. |
PE / Ownership History
| Event | Details |
|---|---|
Acquisition by GE HealthCare (Sale by HgCapital and Others) November 20, 2025 | HgCapital agreed to sell Intelerad to GE HealthCare in a transaction valued at approximately $2.3 billion. This marked Hg's full exit from its majority shareholding in Intelerad. TA Associates and Ardan Equity also exited their minority positions. During Hg's ownership, Intelerad's revenue grew over 3.5 times, with eight acquisitions executed to broaden its product suite. |
Significant Growth Investment by TA Associates (Alongside HgCapital and ST6) July 14, 2022 | TA Associates made a growth investment in Intelerad, joining HgCapital (majority investor) and ST6 (minority investor). This investment aimed to accelerate Intelerad's growth and expand its clinical efficiency and patient care technology. |
Executives
| Name | Background |
|---|---|
Jordan Bazinsky Chief Executive Officer (CEO) | Executive Vice President at Cotiviti, with leadership experience at Cotiviti, Verscend, Verisk Health, and The Advisory Board. MBA from Harvard University and a bachelor's degree from Duke University; also served on Duke's Board of Trustees. |
Karl Johnsen Chief Financial Officer (CFO) | Prior roles include CFO at Rightworks, Trax Retail, and Aspen Technology (NASDAQ: AZPN). Bachelor's degree in accountancy from Bentley University and an MBA from Babson F.W. Olin Graduate School of Business. |
Morris Panner President | Former CEO of Ambra Health. Previously built and sold OpenAir, a business-process software company, to NetSuite (NYSE:N). Bachelor's degree from Yale University and a J.D. from Harvard University. |
Eric Grunden Chief Client Officer | Chief Customer Officer at Uptempo. Held leadership roles at ResMed, Civitas Learning, Greenway Health, and Medical Manager. Bachelor's degree in business administration and information systems from Texas Tech University. |
Chris Hare Chief Growth Officer | Former Chief Revenue Officer at AlayaCare, a cloud-based home health care software provider. Previously Executive Vice President of Sales at Net Health. Bachelor's degree in theology and philosophy from Trevecca Nazarene University. |
Erikka Buracchio Chief People Officer | Former Chief People Officer at Brightly, a Siemens company. Previously Senior Vice President of Global Human Resources at Allscripts Healthcare Solutions. Graduate of Penn State University; holds PHR certification and business professional coaching certificate. |
Pete Srejovic Chief Product & Technology Officer | Former CTO at GTreasury, SHL, and global head of technology at Morningstar. Bachelor's degree in technology and computer information systems from Purdue University. |
Andrew Harris Chief of Staff | Previously held leadership roles at Deloitte, EY, VMware, and Khoros. Former U.S. Army captain. Bachelor's degree in history from Virginia Military Institute, master's in public policy from George Washington University, and MBA from University of Texas McCombs School of Business. |
TA Associates
HgCapital